International Precision Medicine Conference
March 13-15, 2025
Rare Diseases/Disorders and Orphan Drugs
Rare Diseases/Disorders and Orphan Drugs
A disease or condition is considered rare if it affects fewer than one in every 2,000 people in the general population. There are currently about 6,000 known rare diseases, and new ones are being discovered on a regular basis in scientific literature. Word ‘Orphan’ is derived from the Greek term ‘orphanos’, which refers to a child who has lost one or both parents, as well as an adult who has lost a child. Orphan drugs are medications used to diagnose, prevent, or cure rare diseases that are life-threatening or disabling. They're called "orphans" because the pharmaceutical business has little interest in developing and marketing medications for a small proportion of patients with extremely rare diseases under normal market conditions.
- FDA approved drugs
- Efficacy of orphan drugs
Committee Members
Roy Gary Beran
University of New South Wales, Australia
Ewa Danuta Bialek
Institute of Psychosynthesis, Poland
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation IPMC 2022 Speakers
Jinyuan Zhou
Johns Hopkins University School of Medicine, United States
Wei Wu
UCSF, United States
Xu Chen
The College of St. Scholastica, United States
Styliani Geronikolou
University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece